- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00925925
Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
Low birth weight (LBW) status (< 10% for gestational age at birth) is associated with increased risk for diseases such as type II diabetes mellitus, hypertension, chronic obstructive pulmonary disease and coronary artery disease in adults, and represents one example of the "fetal onset of adult disease" hypothesis. Recent data strongly associates LBW status with impaired innate and adaptive immunity leading to increased risk for severe infections during adolescence or early adulthood. Animal studies suggest that the ratio of certain B lymphocyte subpopulations, the B1a and B1b cells, determines whether deficits in immunity occur.
This study will determine the ratio of B1b to B1a lymphocyte subpopulations in the cord blood of infants born LBW in the late preterm to term gestations (> 34 weeks at birth) and compare those ratios with those of normal birth weight (NBW) controls in a nested case control study design.
Furthermore, animal studies suggest that the expression patterns of CD5 and CD19 proteins determines the cellular phenotype of the B lymphocyte, that of a B1a or a B1b cell, and that the regulatory regions controlling their expression are epigenetically vulnerable. The investigators will therefore isolate DNA and RNA from both B lymphocyte subpopulations and determine whether epigenetic changes to the regulatory regions of the genes coding for CD5 and CD19 protein expression occur in LBW lymphocyte subpopulations as compared to the lymphocytes from NBW infants.
This proposal will be the first human study to examine epigenetic determination of a maladaptive phenotype following LBW status at birth in a specific cell type leading to a specific impairment of innate and adaptive immunity.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84108
- University of Utah
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Infants delivered at University of Utah Health Sciences Center
For LBW group:
- Gestational age > or = to 34 0/7 weeks
- Birth weight < or = to 10% for gestational age
For NBW group:
- Term infant controls delivered without complication
- Adequate cord blood sample obtained directly after birth
- Parents or guardians must have signed informed consent
Exclusion Criteria:
- Infants with major congenital anomalies will be excluded
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Normal Birth Weight (NBW)
Term, healthy infants born at normal birth weights
|
Cord blood will be collected from the placentas at delivery for analysis
|
Low Birth Weight (LBW)
Infants born at > or equal to 34 0/7 weeks with a birth weight at < or equal to 10% for gestational age at birth (Small for Gestational Age, SGA)
|
Cord blood will be collected from the placentas at delivery for analysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Characterize and compare the Low Birth Weight(LBW) B lymphocyte subtype B1b with that of Normal Birth Weight(NBW) infants.
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Characterize CD19 and CD5 epigenetic regulation in LBW infants as compared to NBW infants.
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35580
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Birth Weight
-
Society for Applied StudiesGrand Challenges CanadaCompleted
-
Foundation for Advanced Studies on International...St.Luke's Life Science Institute, Tokyo, JapanCompleted
-
Society for Applied StudiesCentre For International HealthCompleted
-
Nantes University HospitalTerminated
-
OSF Healthcare SystemCompleted
-
The Hospital for Sick ChildrenCompletedInfant, Low Birth WeightCanada, Bangladesh
-
Rajiv BahlEmory University; Hawassa University; Mekelle University; Emory University EthiopiaCompleted
-
Addis Ababa UniversityWorld Health Organization; Harvard School of Public Health (HSPH)CompletedLow Birth-weightEthiopia
-
Meiji Co., Ltd.CompletedLow Birth Weight InfantsThailand
-
Aga Khan UniversityBill and Melinda Gates FoundationUnknownLow-Birth-Weight InfantPakistan
Clinical Trials on Cord blood collection for analysis
-
University of AberdeenRecruitingTakotsubo CardiomyopathyUnited Kingdom
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
Sahar M.A. Hassanein, MDWithdrawnIntraventricular Hemorrhage | Respiratory Distress Syndrome | Prematurity | Anemia of PrematurityEgypt
-
Medical Centre LeeuwardenUniversity Medical Center GroningenCompletedHypernatremiaNetherlands
-
Chunxiu GongThe First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsNot yet recruitingGenetic Diseases, Inborn | Small for Gestational Age Infant | Silver-Russell Syndrome
-
University Hospital Center of MartiniqueInstitut Pasteur de Guadeloupe; Centre de Ressources Biologiques de la Martinique...Not yet recruitingSystemic Lupus Erythematosus | Renal DiseaseFrance
-
Mayo ClinicRecruitingHypoplastic Left Heart Syndrome (HLHS)United States
-
University Hospital of SplitNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisInstitut PasteurCompleted
-
Sir Run Run Shaw HospitalNot yet recruitingCatheter ComplicationsChina